IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-02

AUTHORS

Tiziana Vigo, Claudia La Rocca, Deriggio Faicchia, Claudio Procaccini, Maddalena Ruggieri, Marco Salvetti, Diego Centonze, Giuseppe Matarese, Antonio Uccelli,

ABSTRACT

Administration of mesenchymal stem cells (MSC) ameliorate experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), at both clinical and neuropathological levels. The therapeutic properties of MSC in EAE are mainly mediated by the modulation of pathogenic immune response, but other neurotropic effects, including decreased demyelination and axonal loss as well as promotion of tissue repair, play also a role. Properly controlled phase II clinical trials to explore the potential of MSC transplantation as a treatment for MS are underway. Interferon beta (IFNβ) is an approved treatment for relapsing-remitting and secondary progressive MS. Here, we explored the possibility that IFNβ might influence the therapeutic potential of MSC, in view of possible synergistic effects as add-on therapy. IFNβ enhanced the immunomodulatory functions of MSC and induced the expression of secretory leukocyte protease inhibitor (Slpi) and hepatocyte growth factor (Hgf), two soluble mediators involved in immune and regenerative functions of MSC. At molecular level, IFNβ induced a rapid and transient phosphorylation of STAT1 and STAT3, the transcription factors responsible for Slpi and Hgf induction. Concomitantly, IFNβ dynamically affected the activity of mTOR, a key checkpoint in the control of metabolic pathways. Indeed, the impairment of mTOR activity observed early upon exposure to IFNβ, was followed by a long-lasting induction of mTOR signaling, that was associated with an increased glycolytic capacity in MSC. When induced to switch their energetic metabolism towards glycolysis, MSC showed an improved ability to control T-cell proliferation. These results suggest that modifications of MSC energetic metabolism induced by IFNβ may contribute to promote MSC immunomodulatory function and support a role for metabolic pathways in the therapeutic function of MSC. Altogether, these findings support the idea of a combined treatment for MS, in which the immunomodulatory and possibly regenerative activity of MSC could be enhanced by the administration of IFNβ. More... »

PAGES

85

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41419-019-1336-4

DOI

http://dx.doi.org/10.1038/s41419-019-1336-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111669598

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30692524


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "IRCCS Ospedale Policlinico San Martino, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vigo", 
        "givenName": "Tiziana", 
        "id": "sg:person.01266770225.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266770225.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Research Council", 
          "id": "https://www.grid.ac/institutes/grid.5326.2", 
          "name": [
            "Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Naples, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "La Rocca", 
        "givenName": "Claudia", 
        "id": "sg:person.01025736223.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025736223.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Research Council", 
          "id": "https://www.grid.ac/institutes/grid.5326.2", 
          "name": [
            "Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Naples, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Faicchia", 
        "givenName": "Deriggio", 
        "id": "sg:person.0643663503.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643663503.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fondazione Santa Lucia", 
          "id": "https://www.grid.ac/institutes/grid.417778.a", 
          "name": [
            "Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Naples, Italy", 
            "IRCSS Fondazione Santa Lucia, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Procaccini", 
        "givenName": "Claudio", 
        "id": "sg:person.0746561064.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746561064.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bari Aldo Moro", 
          "id": "https://www.grid.ac/institutes/grid.7644.1", 
          "name": [
            "Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari, Bari, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruggieri", 
        "givenName": "Maddalena", 
        "id": "sg:person.012425731200.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012425731200.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Neurologico Mediterraneo", 
          "id": "https://www.grid.ac/institutes/grid.419543.e", 
          "name": [
            "Centre for Experimental Neurological Therapies (CENTERS), Sapienza University, Rome, Italy", 
            "IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salvetti", 
        "givenName": "Marco", 
        "id": "sg:person.010423511144.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010423511144.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Rome Tor Vergata", 
          "id": "https://www.grid.ac/institutes/grid.6530.0", 
          "name": [
            "IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Italy", 
            "Laboratory of Synaptic Immunopathology, Tor Vergata University, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Centonze", 
        "givenName": "Diego", 
        "id": "sg:person.01225277551.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225277551.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Naples Federico II", 
          "id": "https://www.grid.ac/institutes/grid.4691.a", 
          "name": [
            "Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Naples, Italy", 
            "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli \u201cFederico II\u201d, Naples, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matarese", 
        "givenName": "Giuseppe", 
        "id": "sg:person.0604457665.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604457665.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa", 
          "id": "https://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "IRCCS Ospedale Policlinico San Martino, Genoa, Italy", 
            "Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health Unit and Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Uccelli", 
        "givenName": "Antonio", 
        "id": "sg:person.01267455674.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267455674.20"
        ], 
        "type": "Person"
      }, 
      {}
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.immuni.2007.01.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001486507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neulet.2008.10.040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002362658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14653240500319234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004050442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cytogfr.2014.11.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005825923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.21076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007298814"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1742-2094-5-20", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011354027", 
          "https://doi.org/10.1186/1742-2094-5-20"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bph.13674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011381031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jneuroim.2009.08.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012347671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.immuni.2015.08.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013050405"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.immuni.2015.08.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013050405"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(11)70305-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013815923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2005-04-1496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015649537"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cellimm.2011.03.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015656906"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cytogfr.2015.12.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021486405"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.stem.2007.11.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022677414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/glia.20841", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023027577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)03334-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029105810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)03334-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029105810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.expneurol.2005.03.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029434236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.expneurol.2005.03.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029434236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0301-472x(99)00109-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029558055"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-07-035972", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029623399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.0902584", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031377725"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri2395", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034703692", 
          "https://doi.org/10.1038/nri2395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.0803962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034921497"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2567.2011.03451.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039004957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(11)70121-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040742280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/acn3.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048851019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jaci.2016.09.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049768634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nn.3109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050401511", 
          "https://doi.org/10.1038/nn.3109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.20050768", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051513035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/jir.2006.0037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059280689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/jir.2014.0207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059281581"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-017-8625-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092187466", 
          "https://doi.org/10.1007/s00415-017-8625-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jneuroim.2017.11.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1093084635"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02", 
    "datePublishedReg": "2019-02-01", 
    "description": "Administration of mesenchymal stem cells (MSC) ameliorate experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), at both clinical and neuropathological levels. The therapeutic properties of MSC in EAE are mainly mediated by the modulation of pathogenic immune response, but other neurotropic effects, including decreased demyelination and axonal loss as well as promotion of tissue repair, play also a role. Properly controlled phase II clinical trials to explore the potential of MSC transplantation as a treatment for MS are underway. Interferon beta (IFN\u03b2) is an approved treatment for relapsing-remitting and secondary progressive MS. Here, we explored the possibility that IFN\u03b2 might influence the therapeutic potential of MSC, in view of possible synergistic effects as add-on therapy. IFN\u03b2 enhanced the immunomodulatory functions of MSC and induced the expression of secretory leukocyte protease inhibitor (Slpi) and hepatocyte growth factor (Hgf), two soluble mediators involved in immune and regenerative functions of MSC. At molecular level, IFN\u03b2 induced a rapid and transient phosphorylation of STAT1 and STAT3, the transcription factors responsible for Slpi and Hgf induction. Concomitantly, IFN\u03b2 dynamically affected the activity of mTOR, a key checkpoint in the control of metabolic pathways. Indeed, the impairment of mTOR activity observed early upon exposure to IFN\u03b2, was followed by a long-lasting induction of mTOR signaling, that was associated with an increased glycolytic capacity in MSC. When induced to switch their energetic metabolism towards glycolysis, MSC showed an improved ability to control T-cell proliferation. These results suggest that modifications of MSC energetic metabolism induced by IFN\u03b2 may contribute to promote MSC immunomodulatory function and support a role for metabolic pathways in the therapeutic function of MSC. Altogether, these findings support the idea of a combined treatment for MS, in which the immunomodulatory and possibly regenerative activity of MSC could be enhanced by the administration of IFN\u03b2.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/s41419-019-1336-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3798866", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1042939", 
        "issn": [
          "2041-4889"
        ], 
        "name": "Cell Death & Disease", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "IFN\u03b2 enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism", 
    "pagination": "85", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "100fe10e653efe578b1b1aa8888c5eb98a474c824b031819e8063b489667fffb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30692524"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101524092"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41419-019-1336-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111669598"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41419-019-1336-4", 
      "https://app.dimensions.ai/details/publication/pub.1111669598"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T08:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000326_0000000326/records_68466_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/s41419-019-1336-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41419-019-1336-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41419-019-1336-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41419-019-1336-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41419-019-1336-4'


 

This table displays all metadata directly associated to this object as RDF triples.

253 TRIPLES      21 PREDICATES      61 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41419-019-1336-4 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author Nd9d91bc6dc7842aeb61ea615b1438dde
4 schema:citation sg:pub.10.1007/s00415-017-8625-6
5 sg:pub.10.1038/nn.3109
6 sg:pub.10.1038/nri2395
7 sg:pub.10.1186/1742-2094-5-20
8 https://doi.org/10.1002/acn3.84
9 https://doi.org/10.1002/ana.21076
10 https://doi.org/10.1002/glia.20841
11 https://doi.org/10.1016/j.cellimm.2011.03.013
12 https://doi.org/10.1016/j.cytogfr.2014.11.005
13 https://doi.org/10.1016/j.cytogfr.2015.12.001
14 https://doi.org/10.1016/j.expneurol.2005.03.018
15 https://doi.org/10.1016/j.immuni.2007.01.011
16 https://doi.org/10.1016/j.immuni.2015.08.023
17 https://doi.org/10.1016/j.jaci.2016.09.004
18 https://doi.org/10.1016/j.jneuroim.2009.08.007
19 https://doi.org/10.1016/j.jneuroim.2017.11.010
20 https://doi.org/10.1016/j.neulet.2008.10.040
21 https://doi.org/10.1016/j.stem.2007.11.014
22 https://doi.org/10.1016/s0140-6736(98)03334-0
23 https://doi.org/10.1016/s0301-472x(99)00109-5
24 https://doi.org/10.1016/s1474-4422(11)70121-1
25 https://doi.org/10.1016/s1474-4422(11)70305-2
26 https://doi.org/10.1080/14653240500319234
27 https://doi.org/10.1084/jem.20050768
28 https://doi.org/10.1089/jir.2006.0037
29 https://doi.org/10.1089/jir.2014.0207
30 https://doi.org/10.1111/bph.13674
31 https://doi.org/10.1111/j.1365-2567.2011.03451.x
32 https://doi.org/10.1182/blood-2005-04-1496
33 https://doi.org/10.1182/blood-2006-07-035972
34 https://doi.org/10.4049/jimmunol.0803962
35 https://doi.org/10.4049/jimmunol.0902584
36 schema:datePublished 2019-02
37 schema:datePublishedReg 2019-02-01
38 schema:description Administration of mesenchymal stem cells (MSC) ameliorate experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), at both clinical and neuropathological levels. The therapeutic properties of MSC in EAE are mainly mediated by the modulation of pathogenic immune response, but other neurotropic effects, including decreased demyelination and axonal loss as well as promotion of tissue repair, play also a role. Properly controlled phase II clinical trials to explore the potential of MSC transplantation as a treatment for MS are underway. Interferon beta (IFNβ) is an approved treatment for relapsing-remitting and secondary progressive MS. Here, we explored the possibility that IFNβ might influence the therapeutic potential of MSC, in view of possible synergistic effects as add-on therapy. IFNβ enhanced the immunomodulatory functions of MSC and induced the expression of secretory leukocyte protease inhibitor (Slpi) and hepatocyte growth factor (Hgf), two soluble mediators involved in immune and regenerative functions of MSC. At molecular level, IFNβ induced a rapid and transient phosphorylation of STAT1 and STAT3, the transcription factors responsible for Slpi and Hgf induction. Concomitantly, IFNβ dynamically affected the activity of mTOR, a key checkpoint in the control of metabolic pathways. Indeed, the impairment of mTOR activity observed early upon exposure to IFNβ, was followed by a long-lasting induction of mTOR signaling, that was associated with an increased glycolytic capacity in MSC. When induced to switch their energetic metabolism towards glycolysis, MSC showed an improved ability to control T-cell proliferation. These results suggest that modifications of MSC energetic metabolism induced by IFNβ may contribute to promote MSC immunomodulatory function and support a role for metabolic pathways in the therapeutic function of MSC. Altogether, these findings support the idea of a combined treatment for MS, in which the immunomodulatory and possibly regenerative activity of MSC could be enhanced by the administration of IFNβ.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf N11520e80475e4741ab972cd5206bb154
43 Nb2665325dc094fdca072888adc98ed88
44 sg:journal.1042939
45 schema:name IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism
46 schema:pagination 85
47 schema:productId N107f917d56554749b9ba5880eac52a98
48 N82f5242e72144bd7a50ee51882327679
49 N9b3417f800a9496b8fe6f07f8d0f30b2
50 Ncb308622485b431a8e780c585118e450
51 Nefdb62c55695450181c9038470e6e254
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111669598
53 https://doi.org/10.1038/s41419-019-1336-4
54 schema:sdDatePublished 2019-04-11T08:58
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N81b57445f18f4ea5abe34f9c2e5589ad
57 schema:url https://www.nature.com/articles/s41419-019-1336-4
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N107f917d56554749b9ba5880eac52a98 schema:name readcube_id
62 schema:value 100fe10e653efe578b1b1aa8888c5eb98a474c824b031819e8063b489667fffb
63 rdf:type schema:PropertyValue
64 N11520e80475e4741ab972cd5206bb154 schema:issueNumber 2
65 rdf:type schema:PublicationIssue
66 N19ac044a0a634fa8a241d3e1d3ebaa97 rdf:first sg:person.01225277551.06
67 rdf:rest Ncd51acdefac94e85bb3455773f281503
68 N3ab9eeb1517e421ea1d2d8eb92f2790a rdf:first sg:person.01267455674.20
69 rdf:rest N84da171d75d24ab293db73fead1e8ef1
70 N3e3877b3b623493a8b6c14b2e970a7cb rdf:first sg:person.0643663503.73
71 rdf:rest N7c6bfe3714734ecf91f6e53936a45620
72 N7c6bfe3714734ecf91f6e53936a45620 rdf:first sg:person.0746561064.49
73 rdf:rest N811100bbd0da4c22a2644d59ccadce61
74 N811100bbd0da4c22a2644d59ccadce61 rdf:first sg:person.012425731200.89
75 rdf:rest N8e509239537a4e01b4c9d9f372d82094
76 N81b57445f18f4ea5abe34f9c2e5589ad schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 N82f5242e72144bd7a50ee51882327679 schema:name doi
79 schema:value 10.1038/s41419-019-1336-4
80 rdf:type schema:PropertyValue
81 N84da171d75d24ab293db73fead1e8ef1 rdf:first N3f1d9c981aa64312ab41b0cfb4d2c7e4
82 rdf:rest rdf:nil
83 N8e509239537a4e01b4c9d9f372d82094 rdf:first sg:person.010423511144.12
84 rdf:rest N19ac044a0a634fa8a241d3e1d3ebaa97
85 N9b3417f800a9496b8fe6f07f8d0f30b2 schema:name dimensions_id
86 schema:value pub.1111669598
87 rdf:type schema:PropertyValue
88 Nab7e58acf9a74d4cb21e51b337303b0c schema:name IRCCS Ospedale Policlinico San Martino, Genoa, Italy
89 rdf:type schema:Organization
90 Nb2665325dc094fdca072888adc98ed88 schema:volumeNumber 10
91 rdf:type schema:PublicationVolume
92 Ncb308622485b431a8e780c585118e450 schema:name pubmed_id
93 schema:value 30692524
94 rdf:type schema:PropertyValue
95 Ncd51acdefac94e85bb3455773f281503 rdf:first sg:person.0604457665.08
96 rdf:rest N3ab9eeb1517e421ea1d2d8eb92f2790a
97 Nd9d91bc6dc7842aeb61ea615b1438dde rdf:first sg:person.01266770225.38
98 rdf:rest Nfbcd7636995d4b999e33e0b24997ac06
99 Nefdb62c55695450181c9038470e6e254 schema:name nlm_unique_id
100 schema:value 101524092
101 rdf:type schema:PropertyValue
102 Nfbcd7636995d4b999e33e0b24997ac06 rdf:first sg:person.01025736223.36
103 rdf:rest N3e3877b3b623493a8b6c14b2e970a7cb
104 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
105 schema:name Medical and Health Sciences
106 rdf:type schema:DefinedTerm
107 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
108 schema:name Immunology
109 rdf:type schema:DefinedTerm
110 sg:grant.3798866 http://pending.schema.org/fundedItem sg:pub.10.1038/s41419-019-1336-4
111 rdf:type schema:MonetaryGrant
112 sg:journal.1042939 schema:issn 2041-4889
113 schema:name Cell Death & Disease
114 rdf:type schema:Periodical
115 sg:person.01025736223.36 schema:affiliation https://www.grid.ac/institutes/grid.5326.2
116 schema:familyName La Rocca
117 schema:givenName Claudia
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025736223.36
119 rdf:type schema:Person
120 sg:person.010423511144.12 schema:affiliation https://www.grid.ac/institutes/grid.419543.e
121 schema:familyName Salvetti
122 schema:givenName Marco
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010423511144.12
124 rdf:type schema:Person
125 sg:person.01225277551.06 schema:affiliation https://www.grid.ac/institutes/grid.6530.0
126 schema:familyName Centonze
127 schema:givenName Diego
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225277551.06
129 rdf:type schema:Person
130 sg:person.012425731200.89 schema:affiliation https://www.grid.ac/institutes/grid.7644.1
131 schema:familyName Ruggieri
132 schema:givenName Maddalena
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012425731200.89
134 rdf:type schema:Person
135 sg:person.01266770225.38 schema:affiliation Nab7e58acf9a74d4cb21e51b337303b0c
136 schema:familyName Vigo
137 schema:givenName Tiziana
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266770225.38
139 rdf:type schema:Person
140 sg:person.01267455674.20 schema:affiliation https://www.grid.ac/institutes/grid.5606.5
141 schema:familyName Uccelli
142 schema:givenName Antonio
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267455674.20
144 rdf:type schema:Person
145 sg:person.0604457665.08 schema:affiliation https://www.grid.ac/institutes/grid.4691.a
146 schema:familyName Matarese
147 schema:givenName Giuseppe
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604457665.08
149 rdf:type schema:Person
150 sg:person.0643663503.73 schema:affiliation https://www.grid.ac/institutes/grid.5326.2
151 schema:familyName Faicchia
152 schema:givenName Deriggio
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643663503.73
154 rdf:type schema:Person
155 sg:person.0746561064.49 schema:affiliation https://www.grid.ac/institutes/grid.417778.a
156 schema:familyName Procaccini
157 schema:givenName Claudio
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746561064.49
159 rdf:type schema:Person
160 sg:pub.10.1007/s00415-017-8625-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092187466
161 https://doi.org/10.1007/s00415-017-8625-6
162 rdf:type schema:CreativeWork
163 sg:pub.10.1038/nn.3109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050401511
164 https://doi.org/10.1038/nn.3109
165 rdf:type schema:CreativeWork
166 sg:pub.10.1038/nri2395 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034703692
167 https://doi.org/10.1038/nri2395
168 rdf:type schema:CreativeWork
169 sg:pub.10.1186/1742-2094-5-20 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011354027
170 https://doi.org/10.1186/1742-2094-5-20
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1002/acn3.84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048851019
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1002/ana.21076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007298814
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1002/glia.20841 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023027577
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/j.cellimm.2011.03.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015656906
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1016/j.cytogfr.2014.11.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005825923
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1016/j.cytogfr.2015.12.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021486405
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/j.expneurol.2005.03.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029434236
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/j.immuni.2007.01.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001486507
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.immuni.2015.08.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013050405
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.jaci.2016.09.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049768634
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.jneuroim.2009.08.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012347671
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.jneuroim.2017.11.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1093084635
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.neulet.2008.10.040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002362658
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/j.stem.2007.11.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022677414
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/s0140-6736(98)03334-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029105810
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/s0301-472x(99)00109-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029558055
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s1474-4422(11)70121-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040742280
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/s1474-4422(11)70305-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013815923
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1080/14653240500319234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004050442
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1084/jem.20050768 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051513035
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1089/jir.2006.0037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059280689
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1089/jir.2014.0207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059281581
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1111/bph.13674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011381031
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1111/j.1365-2567.2011.03451.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039004957
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1182/blood-2005-04-1496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015649537
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1182/blood-2006-07-035972 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029623399
223 rdf:type schema:CreativeWork
224 https://doi.org/10.4049/jimmunol.0803962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034921497
225 rdf:type schema:CreativeWork
226 https://doi.org/10.4049/jimmunol.0902584 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031377725
227 rdf:type schema:CreativeWork
228 https://www.grid.ac/institutes/grid.417778.a schema:alternateName Fondazione Santa Lucia
229 schema:name IRCSS Fondazione Santa Lucia, Rome, Italy
230 Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Naples, Italy
231 rdf:type schema:Organization
232 https://www.grid.ac/institutes/grid.419543.e schema:alternateName Istituto Neurologico Mediterraneo
233 schema:name Centre for Experimental Neurological Therapies (CENTERS), Sapienza University, Rome, Italy
234 IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Italy
235 rdf:type schema:Organization
236 https://www.grid.ac/institutes/grid.4691.a schema:alternateName University of Naples Federico II
237 schema:name Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli “Federico II”, Naples, Italy
238 Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Naples, Italy
239 rdf:type schema:Organization
240 https://www.grid.ac/institutes/grid.5326.2 schema:alternateName National Research Council
241 schema:name Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), Naples, Italy
242 rdf:type schema:Organization
243 https://www.grid.ac/institutes/grid.5606.5 schema:alternateName University of Genoa
244 schema:name Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health Unit and Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy
245 IRCCS Ospedale Policlinico San Martino, Genoa, Italy
246 rdf:type schema:Organization
247 https://www.grid.ac/institutes/grid.6530.0 schema:alternateName University of Rome Tor Vergata
248 schema:name IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Italy
249 Laboratory of Synaptic Immunopathology, Tor Vergata University, Rome, Italy
250 rdf:type schema:Organization
251 https://www.grid.ac/institutes/grid.7644.1 schema:alternateName University of Bari Aldo Moro
252 schema:name Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari, Bari, Italy
253 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...